{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:16:21Z","timestamp":1781057781587,"version":"3.54.1"},"reference-count":48,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00995"],"award-info":[{"award-number":["PI18\/00995"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Grant PRB3 (IPT17\/0019\u2014ISCIII-SGEFI\/ERDF)"],"award-info":[{"award-number":["Grant PRB3 (IPT17\/0019\u2014ISCIII-SGEFI\/ERDF)"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","award":["PIE 202020E108"],"award-info":[{"award-number":["PIE 202020E108"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>The COVID-19 pandemic represents an unprecedented global challenge in this century. COVID-19 is a viral respiratory infection, yet the clinical characteristics of this infection differ in spinal cord injury patients from those observed in the general population. Cough and asthenia are the most frequent symptoms in this population. Moreover, infected spinal cord injury patients rarely present complications that require admission to an Intensive Care Unit, in contrast to the general population. Thus, there is a clear need to understand how COVID-19 affects spinal cord injury patients from a molecular perspective. Here, we employed an -omics strategy in order to identify variations in protein abundance in spinal cord injury patients with and without COVID-19. After a quantitative differential analysis using isobaric tags and mass spectrometry and a verification phase, we have found differences mainly related to coagulation and platelet activation. Our results suggest a key role of heparin in the response of spinal cord injury patients to COVID-19 infection, showing a significant correlation between these proteins and heparin dose. Although the number of patients is limited, these data may shed light on new therapeutic options to improve the management these patients and, possibly, those of the general population as well.<\/jats:p>","DOI":"10.3390\/jpm10040182","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T10:14:22Z","timestamp":1603275262000},"page":"182","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Why Does COVID-19 Affect Patients with Spinal Cord Injury Milder? A Case-Control Study: Results from Two Observational Cohorts"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9096-5233","authenticated-orcid":false,"given":"Enrique","family":"Calvo","sequence":"first","affiliation":[{"name":"Proteomics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain"},{"name":"Cardiovascular Proteomics Laboratory and CIBER-CV, CNIC, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Corbacho-Alonso","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos (HNP), SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Sastre-Oliva","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos (HNP), SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Nu\u00f1ez","sequence":"additional","affiliation":[{"name":"Proteomics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Baena-Galan","sequence":"additional","affiliation":[{"name":"Proteomics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Hernandez-Fernandez","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos (HNP), SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Rodriguez-Cola","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Nacional de Parapl\u00e9jicos SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Jimenez-Velasco","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Nacional de Parapl\u00e9jicos SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0231-5159","authenticated-orcid":false,"given":"Fernando J.","family":"Corrales","sequence":"additional","affiliation":[{"name":"Proteomics Facility, Centro Nacional de Biotecnolog\u00eda (CNB), 28049 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gambarrutta-Malfati","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Nacional de Parapl\u00e9jicos SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gutierrez-Henares","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Hospital Nacional de Parapl\u00e9jicos, SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Lopez-Dolado","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Hospital Nacional de Parapl\u00e9jicos, SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Gil-Agudo","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Hospital Nacional de Parapl\u00e9jicos, SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-5092","authenticated-orcid":false,"given":"Jesus","family":"Vazquez","sequence":"additional","affiliation":[{"name":"Proteomics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain"},{"name":"Cardiovascular Proteomics Laboratory and CIBER-CV, CNIC, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mourino-Alvarez","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos (HNP), SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Barderas","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos (HNP), SESCAM, 45071 Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics ofcoronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus infections\u2014More than just the common cold","volume":"323","author":"Paules","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health\u2014The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMe2002387","article-title":"Covid-19\u2014Navigating the Uncharted","volume":"382","author":"Fauci","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12974-016-0736-y","article-title":"Multiple organ dysfunction and systemic inflammation after spinal cord injury: A complex relationship","volume":"13","author":"Sun","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_6","unstructured":"Center, J.H.C.R. (2020, July 15). Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available online: https:\/\/www.arcgis.com\/apps\/opsdashboard\/index.html."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0031-1296049","article-title":"Diagnosis and prognosis of traumatic spinal cord injury","volume":"1","author":"Goss","year":"2011","journal-title":"Glob. Spine J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/wound.2019.0968","article-title":"Comprehensive proteomic profiling of pressure ulcers in patients with spinal cord injury identifies a specific protein pattern of pathology","volume":"9","author":"Lopez","year":"2020","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"ref_9","first-page":"168757","article-title":"Respiratory management in the patient with spinal cord injury","volume":"2013","author":"RascadoSedes","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1389201015666141031121338","article-title":"A review on response of immune system in spinal cord injury and therapeutic agents useful in treatment","volume":"16","author":"Kasinathan","year":"2015","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1460-9568.2007.05447.x","article-title":"Spinal cord injury-induced immune depression syndrome (SCI-IDS)","volume":"25","author":"Riegger","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3389\/fimmu.2018.02365","article-title":"Elevated autoantibodies in subacute human spinal cord injury are naturally occurring antibodies","volume":"9","author":"Grassner","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/WNL.0000000000003652","article-title":"Long-term functional outcome in patients with acquired infections after acute spinal cord injury","volume":"88","author":"Kopp","year":"2017","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41393-019-0350-9","article-title":"The 2019 revision of the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)\u2014What\u2019s new?","volume":"57","author":"Betz","year":"2019","journal-title":"Spinal Cord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1038\/s41598-018-23037-7","article-title":"Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals","volume":"8","author":"Lopez","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1074\/mcp.M700239-MCP200","article-title":"Properties of average score distributions of SEQUEST","volume":"7","author":"Navarro","year":"2008","journal-title":"Mol. Cell. Proteom."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1021\/pr800362h","article-title":"A refined method to calculate false discovery rates for peptide identification using decoy databases","volume":"8","author":"Navarro","year":"2009","journal-title":"J. Proteome. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1074\/mcp.M115.055905","article-title":"A novel systems-biology algorithm for the analysis of coordinated protein responses using quantitative proteomics","volume":"15","author":"Camafeita","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41394-020-0284-7","article-title":"COVID-19: Screening and triage challenges in people with disability due to Spinal Cord Injury","volume":"6","author":"Korupolu","year":"2020","journal-title":"Spinal Cord Ser. Cases"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41394-020-0288-3","article-title":"Clinical features of coronavirus disease 2019 (COVID-19) in a cohort of patients with disability due to spinal cord injury","volume":"6","year":"2020","journal-title":"Spinal Cord Ser. Cases"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41394-020-0289-2","article-title":"Atypical presentation of Covid-19 in persons with spinal cord injury","volume":"6","author":"Dicks","year":"2020","journal-title":"Spinal Cord Ser. Cases"},{"key":"ref_23","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2014.10.005","article-title":"Synergistic effect of signaling from receptors of soluble platelet agonists and outside-in signaling in formation of a stable fibrinogen-integrin \u03b1IIb\u03b23-actin cytoskeleton complex","volume":"135","author":"Budnik","year":"2015","journal-title":"Thromb. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1182\/blood-2010-09-305433","article-title":"Talin\u2014Dependent integrin activation is required for fibrin clot retraction by platelets","volume":"117","author":"Haling","year":"2011","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1160\/TH17-03-069","article-title":"Molecular signature of coronary stent thrombosis: Oxidative stress and innate immunity cells","volume":"117","author":"Cubedo","year":"2017","journal-title":"Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09537104.2011.654004","article-title":"New insights into the versatile roles of platelet FlnA","volume":"24","author":"Falet","year":"2013","journal-title":"Platelets"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1182\/blood.2019000014","article-title":"FilaminA: Key actor in platelet biology","volume":"134","author":"Rosa","year":"2019","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MBC.0000000000000923","article-title":"Familial macro thrombocytopenia: Role of genetics where morphology fails","volume":"31","author":"Chaudhary","year":"2020","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/09537104.2015.1064882","article-title":"Thrombin generation in two families with MYH9-related platelet disorder","volume":"27","author":"Zetterberg","year":"2016","journal-title":"Platelets"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1016\/S0021-9258(18)69022-2","article-title":"Functional and structural similarities between protease nexin I and C1 inhibitor","volume":"263","author":"McKay","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1054\/fipr.2000.0054","article-title":"Fibrinogen functions and fibrin assembly","volume":"14","author":"Mosesson","year":"2000","journal-title":"Fibrinolysis Proteolysis"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Messner, C.B., Demichev, V., Wendisch, D., Michalick, L., White, M., Freiwald, A., Textoris-Taube, K., Vernardis, S.I., Egger, A.S., and Kreidl, M. (2020). Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst.","DOI":"10.1016\/j.cels.2020.05.012"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"10083","DOI":"10.1128\/JVI.79.15.10083-10087.2005","article-title":"The severe acute respiratory syndrome coronavirus 3a protein up-regulates expression of fibrinogen in lung epithelial cells","volume":"79","author":"Tan","year":"2005","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-020-02134-3","article-title":"COVID-19 update: Covid-19-associated coagulopathy","volume":"50","author":"Becker","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1076029620933945","DOI":"10.1177\/1076029620933945","article-title":"COVID-19 may predispose to thrombosis by affecting both vascular endothelium and platelets","volume":"26","author":"Cure","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_37","first-page":"29","article-title":"Haptoglobin phenotypes, which one is better and when?","volume":"52","author":"Zvi","year":"2006","journal-title":"Clin. Lab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/pmic.200500638","article-title":"Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase","volume":"6","author":"Wan","year":"2006","journal-title":"Proteomics"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sengupta, M.B., Basu, M., Iswarari, S., Mukhopadhyay, K.K., Sardar, K.P., Acharyya, B., Mohanty, P.K., and Mukhopadhyay, D. (2014). CSF proteomics of secondary phase spinal cord injury in human subjects: Perturbed molecular pathways post injury. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0110885"},{"key":"ref_40","first-page":"219","article-title":"Role of haptoglobin in free hemoglobin metabolism","volume":"6","author":"Lim","year":"2001","journal-title":"Redox Rep. Commun. Free Radic. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/pmic.200300787","article-title":"Antioxidant role of human haptoglobin","volume":"4","author":"Tseng","year":"2004","journal-title":"Proteomics"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Yuan, X., Huang, W., Ye, B., Chen, C., Huang, R., Wu, F., Wei, Q., Zhang, W., and Hu, J. (2020). Changes of hematological and immunological parameters in COVID-19 patients. Int. J. Hematol., 1\u20137.","DOI":"10.1007\/s12185-020-02930-w"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.htct.2020.03.001","article-title":"Hemoglobin value may be decreased in patients with severe coronavirus disease 2019","volume":"42","author":"Lippi","year":"2020","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/rth2.12353","article-title":"Using heparin molecules to manage COVID-2019","volume":"4","author":"Liu","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jth.14821","article-title":"The versatile heparin in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"104873","DOI":"10.1016\/j.antiviral.2020.104873","article-title":"Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions","volume":"181","author":"Kim","year":"2020","journal-title":"Antiviral. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41421-020-00192-8","article-title":"Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro","volume":"6","author":"Kwon","year":"2020","journal-title":"Cell Discov."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Gozzo, L., Viale, P., Longo, L., Vitale, D.C., and Drago, F. (2020). The potential role of heparin in patients with COVID-19: Beyond the anticoagulant effect. A review. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01307"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/10\/4\/182\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:25:15Z","timestamp":1760178315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/10\/4\/182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["jpm10040182"],"URL":"https:\/\/doi.org\/10.3390\/jpm10040182","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]}}}